Results 11 to 20 of about 3,030,015 (277)

Macrophage activation syndrome and COVID-19 [PDF]

Inflammation and Regeneration, 2020
An emerging, rapidly spreading coronavirus SARS-CoV-2 is causing a devastating pandemic. As we have not developed curative medicine and effective vaccine, the end of this life-threatening infectious disease is still unclear.
Ryo Otsuka, Ken-ichiro Seino
doaj   +4 more sources

A Review on Macrophage Activation Syndrome

Journal of Pure and Applied Microbiology, 2019
MAS, which is currently grouped under secondary or acquired haemophagocytic lymphohistiocytosis (sHLH), is a rare and fatal disorder that results from excess activation of T-cells and macrophages.
Preeti Sharma, Shailza Shreshtha, Pradeep Kumar, Rachna Sharma, T.K. Mahapatra   +4 more
doaj   +4 more sources

Macrophage Activation Syndrome in Children:Diagnosis and Management [PDF]

Indian Pediatrics, 2021
Macrophage activation syndrome is a severe yet under-recognized complication encountered in pediatric rheumatology. It manifests as secondary hemophagocytic lymphohistiocytosis leading to a hyper-inflammatory state resulting from an underlying cytokine ...
Gupta, Latika, Ramanan, A. V., Gupta, Latika; id_orcid, Sen, Ethan S, Ramanan, A V, Bagri, Narendra Kumar, Sen, Ethan S., A. V. Ramanan, Ethan S. Sen, Latika Gupta, Narendra Kumar Bagri   +10 more
core   +8 more sources

Does early treatment of macrophage activation syndrome prevent fatal outcome in patients with severe systemic juvenile idiopathic arthritis?

Rheumatology, 2014
Macrophage activation syndrome (MAS), a rare complication of various diseases, mainly systemic inflammatory connective tissue disorders, is being increasingly recognized.
Marzena Janczewska, Teresa Kołcun-Penkowska   +1 more
doaj   +2 more sources

Macrophage activation syndrome in pediatrics [PDF]

Pediatric Allergy and Immunology, 2020
: Macrophage activation syndrome (MAS) is a serious, potentially life-threatening, hyperinflammatory condition, which belongs to the spectrum of hemophagocytic lymphohistiocytosis (HLH) and can complicate several immunologic and rheumatic disorders.
Alessandra Alongi, Alongi A., Naddei, Roberta, Ravelli A., Natoli V., Angelo Ravelli, De Miglio L., Alongi, Alessandra, Ravelli, Angelo, Natoli, Valentina, De Miglio, Laura, Naddei R., Laura De Miglio, Valentina Natoli, Roberta Naddei   +14 more
core   +4 more sources

The Immunology of Macrophage Activation Syndrome [PDF]

Frontiers in Immunology, 2019
Synonymous with secondary hemophagocytic lymphohistiocytosis, macrophage activation syndrome (MAS) is a term used by rheumatologists to describe a potentially life-threatening complication of systemic inflammatory disorders, most commonly systemic ...
Courtney B. Crayne, Sabrin Albeituni, Kim E. Nichols, Randy Q. Cron   +3 more
doaj   +3 more sources

Macrophage activation syndrome in a child with varicella: a case report [PDF]

Journal of Medical Case Reports
Background Macrophage activation syndrome is a severe, potentially fatal condition that belongs to the group of hemophagocytic lymphohistiocytosis.
H. Mateiko, O. Synoverska, M. Matvisiv, Z. Vovk, N. Horbal   +4 more
doaj   +2 more sources

Unmasking macrophage activation syndrome in VEXAS syndrome: a diagnostic challenge [PDF]

European Journal of Case Reports in Internal Medicine
Introduction: Vacuoles, E1 Enzyme, X-linked, Auto-inflammatory, Somatic (VEXAS) syndrome is a late-onset autoinflammatory disease caused by somatic mutations in the UBA1gene.
Alexandre Boissais, Baptiste Farrulo, Thomas Moulinet, Valentin Lacombe, Alexandra Audemard-Verger   +4 more
doaj   +2 more sources

Macrophage activation syndrome.

Current Opinion in Rheumatology, 2002
Macrophage activation syndrome (MAS) is a serious complication of childhood systemic inflammatory disorders that is thought to be caused by excessive activation and proliferation of T lymphocytes and macrophages.
RAVELLI, ANGELO
core   +5 more sources

Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome

Case Reports in Rheumatology, 2021
Systemic juvenile idiopathic arthritis (sJIA) is characterized by arthritis, fever, rash, lymphadenopathy, hepatosplenomegaly, and serositis. Macrophage activation syndrome is the most feared complication of sJIA with a high risk of mortality.
Nicole Davidson, Hemalatha G. Rangarajan, Kyla Driest, Rajinder P. S. Bajwa, Veronika Polishchuk, Rolla F. Abu-Arja   +5 more
doaj   +2 more sources